NITRESS

This brand name is authorized in Nigeria.

Active ingredients

The drug NITRESS contains one active pharmaceutical ingredient (API):

1	Zopiclone UNII 03A5ORL08Q - ZOPICLONE
	Zopiclone is a hypnotic agent belonging to the cyclopyrrolone class of psychotherapeutic agents. It rapidly initiates and sustains sleep without reduction of total REM sleep and with preservation of slow wave sleep. Negligible residual effects are seen the following morning. Its pharmacological properties include hypnotic, sedative, anxiolytic, anticonvulsant and muscle-relaxant actions.
	Read more about Zopiclone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-6316	Tablet	NITRESS TABLETS TAB 7.5 mg	NITRESS TABLETS B4-6316 NITRESS TABLETS ZOPICLONE 7.5MG LACTOSE 24.130MG MICROCRYSTALLINE CELLULOSE 81.521 CROSCARMELLOSE SODIUM 0.3MG MAGNESIUM STEARATE 1.0MG COLLOIDAL ANHYDROUS SILICA 1.0MG PURIFIED TALC 0.5MG HYDROXY PROPYL MTHYLCELLULOSE 15 CPS 2.1MG TITANIUM DIOXIDE 2.0MG ISOPROPYL ALCOHOL 0.02ML METHYLENE CHLORIDE 0.04ML PROPYLENE GLYCOL0.0006ML Prescription Only Medicine (POM) TETA PHARMACEUTICALS NIG LTD, PLOT A28, MOKOLA EXTENSION, IBADAN LESANTO LABORATORIES, Plot 9,10,11,&20 survey no 53 palghar east 401404. India, India 2/23/2023 2/22/2028	23/02/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05CF01	Zopiclone	N Nervous system → N05 Psycholeptics → N05C Hypnotics and sedatives → N05CF Benzodiazepine related drugs
Discover more medicines within N05CF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-6316